ProfileGDS5678 / 1455852_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 40% 41% 41% 42% 41% 39% 39% 41% 41% 41% 41% 39% 40% 41% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.9591640
GSM967853U87-EV human glioblastoma xenograft - Control 22.945641
GSM967854U87-EV human glioblastoma xenograft - Control 32.9490141
GSM967855U87-EV human glioblastoma xenograft - Control 42.9128742
GSM967856U87-EV human glioblastoma xenograft - Control 52.9045641
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.969439
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.9594939
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9281941
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9300241
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.9274241
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.9287441
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.8599139
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.9189340
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9371141